Barriers to timely diagnosis and treatment of cutaneous T-cell lymphoma in people with intellectual disabilities

Read full text
Authors: Brigit A. Lapolla, Sara Suhl, Yoni Sacknovitz, Emily R. Gordon, Celine M. Schreidah, Caroline Chen, Ikenna David Nebo, Lauren M. Fahmy, Larisa J. Geskin
Cited by: 0
References: 9

Abstract

People with intellectual disabilities (ID) experience significant healthcare disparities, including lower rates of cancer screening, delayed diagnosis, and reduced access to intensive treatments compared to the general population.1-4 Among cancers, cutaneous T-cell lymphoma (CTCL) illustrates clear challenges associated with these disparities. Mycosis fungoides (MF), the most common form of CTCL, is stratified into progressive clinical stages: patch, plaque, and tumor, with the clinical stage at diagnosis guiding therapeutic strategies and prognosis.

Fields of Study & Subjects

Cutaneous lymphoproliferative disorders research Dermatology and Skin Diseases Nonmelanoma Skin Cancer Studies

Publication details

Journal / source
JAAD Case Reports
Volume
70
Pages
72–75
Publication date
9 February 2026
Language
EN